Mintz represented Delta Associated Investigations, a tech-enabled national provider of investigative and claims support ...

Artificial intelligence (AI) has emerged as an influential technology, driving notable investments across various industries in recent years. In 2024, venture capital (VC) funding for AI companies ...

Mintz represented the US Department of Energy in the closing of two separate loans totaling up to approximately $5.1 billion for subsidiaries of Alliant Energy Corporation. The financings will support ...

The Inflation Reduction Act (IRA) continues to reshape the US drug‑pricing landscape as federal implementation accelerates and market responses evolve. In 2025, regulators advanced core IRA programs ...

Mitch Frazer, Managing Partner of Mintz's Toronto office, has received an honorary Doctor of Laws degree from Western ...

On June 30, 2025, New Jersey enacted legislation that now incorporates the US federal qualified small business stock (QSBS) rules under Section[1] 1202, effective for dispositions of QSBS for tax ...

Michael Renaud, Chair of Mintz’s Intellectual Property Division, has been named to IAM Global Leaders 2027, a guide ...

On June 16, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a request for information (RFI) titled “Pharmacy Benefit Manager Compensation and Data Collection,” seeking industry input ...

Mintz’s Managed Care, PBMs & Pharmacies practice is pleased to present a combined Summer / Fall 2025 PBM Policy and Legislative Update. This edition builds upon prior issues and summarizes activity ...

Alex regularly represents issuers, underwriters, sponsors, investors, and investment banks in cross-border financings and ...

On May 19, 2026, the Financial Industry Regulatory Authority (“FINRA”) announced that it is conducting a targeted review of how member firms supervise the sale of higher-risk structured products.